Global Emergency Unblinding Service

  • Medic team available 24/7
  • Immediate access to Study Protocol and IB
  • Care to avoid unnecessary unblinding
  • SAEs reported to Sponsor Pharmacovigilance within 24 hours
  • IRT agnostic
  • Serious breach reporting helpline for EMA-approved trials

Supporting your clinical trial with emergency unblinding, available 24/7, seven days a week

With a global reach supporting over 300 studies covering more than 110 thousand patients in 80 countries and with over 45 languages our background and culture are built on providing support in emergency situations. Our unparalleled experience in providing 24/7 emergency response services allows us to provide strategic solutions to small, medium and global pharma companies.

Many in-house solutions can be fragmented and may be susceptible to failure which can result in major findings or serious breaches during a regulatory inspection.

We receive many enquiries following such a regulatory inspection, suggesting that even the most comprehensive provision by a CRO or internal mechanism still may not be robust enough to stand up to scrutiny from the regulators.

    Not quite sure? Register your interest and we will be in touch.


      • Support in 45 languages

      • Available 24/7 365 days/yr

      • Operates worldwide

      Our helpline is especially focused on supporting clinical trials

      ESMS has a long track record of directly supporting HCPs involved with clinical trials. We provide an immediate, ever-present point of contact regarding any help or information that is required.

      Alongside the reassurance given to HCPs, we seamlessly integrate with your current trial management processes in order to provide the required trial data.

      Our clients

      Contact us

      Call us on 0044 207 113 7878 or email rita.fitzpatrick@esmsglobal.com

      Or complete our enquiry form to find out how we can support your next study.